Skip to main content

Transforming the understanding
and treatment of mental illnesses.

Celebrating 75 Years! Learn More >>

 Archived Content

The National Institute of Mental Health archives materials that are over 4 years old and no longer being updated. The content on this page is provided for historical reference purposes only and may not reflect current knowledge or information.

Innovative Measures of Medication Adherence for HIV Treatment and Prevention


March 13–14, 2017


Rockville, MD

The NIMH Division of AIDS Research co-sponsored a meeting with the National Institute of Allergy and Infectious Diseases (NIAID) to advance the next-generation of HIV medication adherence. The meeting convened eleven research teams that are working to develop and validate innovative assessments of oral antiretroviral medication adherence under a recent NIMH-NIAID collaborative request for applications (RFA-AI-14-071 ). The meeting highlighted novel drug assays, pill ingestion sensors, and wireless technologies that provide real-time and point-of-care adherence assessments. Meeting discussions centered on opportunities for collaboration and harmonization, and charting the path for regulatory approval and clinical use.